 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, September 15, 2002, 22(18):8312-8323
Chronic Morphine Induces Downregulation of Spinal Glutamate Transporters: Implications in Morphine Tolerance and Abnormal Pain Sensitivity
Jianren Mao1, Backil Sung1, Ru-Rong Ji2, and Grewo Lim1 1 Massachusetts General Hospital Pain Center and 2 Neural Plasticity Research Group, Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114
Tolerance to the analgesic effects of an opioid occurs after its chronic administration, a pharmacological phenomenon that has been associated with the development of abnormal pain sensitivity such as hyperalgesia. In the present study, we examined the role of spinal glutamate transporters (GTs) in the development of both morphine tolerance and associated thermal hyperalgesia. Chronic morphine administered through either intrathecal boluses or continuous infusion induced a dose-dependent downregulation of GTs (EAAC1 and GLAST) in the rat's superficial spinal cord dorsal horn. This GT downregulation was mediated through opioid receptors because naloxone blocked such GT changes. Morphine-induced GT downregulation reduced the ability to maintain in vivo glutamate homeostasis at the spinal level, because the hyperalgesic response to exogenous glutamate was enhanced, including an increased magnitude and a prolonged time course, in morphine-treated rats with reduced spinal GTs. Moreover, the downregulation of spinal GTs exhibited a temporal correlation with the development of morphine tolerance and thermal hyperalgesia. Consistently, the GT inhibitor L-trans-pyrrolidine-2-4-dicarboxylate (PDC) potentiated, whereas the positive GT regulator riluzole reduced, the development of both morphine tolerance and thermal hyperalgesia. The effects from regulating spinal GT activity by PDC were at least in part mediated through activation of the NMDA receptor (NMDAR), because the noncompetitive NMDAR antagonist MK-801 blocked both morphine tolerance and thermal hyperalgesia that were potentiated by PDC. These results indicate that spinal GTs may contribute to the neural mechanisms of morphine tolerance and associated abnormal pain sensitivity by means of regulating regional glutamate homeostasis.
Key words: tolerance; opioid; glutamate transporter; NMDA; hyperalgesia; riluzole; PDC
Copyright © 2002 Society for Neuroscience 0270-6474/02/22188312-12$05.00/0
This article has been cited by other articles:
C. Li, X. Zhao, X. Cao, D. Chu, J. Chen, and J. Zhou
The Drosophila Homolog of jwa is Required for Ethanol Tolerance
Alcohol Alcohol., September 1, 2008; 43(5): 529 - 536.
[Abstract] [Full Text] [PDF]
L. Yang, S. Wang, B. Sung, G. Lim, and J. Mao
Morphine Induces Ubiquitin-Proteasome Activity and Glutamate Transporter Degradation
J. Biol. Chem., August 1, 2008; 283(31): 21703 - 21713.
[Abstract] [Full Text] [PDF]
Y. Chen, C. Geis, and C. Sommer
Activation of TRPV1 Contributes to Morphine Tolerance: Involvement of the Mitogen-Activated Protein Kinase Signaling Pathway
J. Neurosci., May 28, 2008; 28(22): 5836 - 5845.
[Abstract] [Full Text] [PDF]
A. Singla, M. P. Stojanovic, L. Chen, and J. Mao
A Differential Diagnosis of Hyperalgesia, Toxicity, and Withdrawal from Intrathecal Morphine Infusion
Anesth. Analg., December 1, 2007; 105(6): 1816 - 1819.
[Abstract] [Full Text] [PDF]
G.-J. Wu, Z.-H. Wen, W.-F. Chen, Y.-C. Chang, C.-H. Cherng, and C.-S. Wong
The Effect of Dexamethasone on Spinal Glutamine Synthetase and Glutamate Dehydrogenase Expression in Morphine-Tolerant Rats
Anesth. Analg., March 1, 2007; 104(3): 726 - 730.
[Abstract] [Full Text] [PDF]
J. J. Xu, B. C. Walla, M. F. Diaz, G. N. Fuller, and H. B. Gutstein
Intermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance.
Anesth. Analg., September 1, 2006; 103(3): 714 - 720.
[Abstract] [Full Text] [PDF]
G. Lim, S. Wang, Q. Zeng, B. Sung, L. Yang, and J. Mao
Expression of Spinal NMDA Receptor and PKC{gamma} after Chronic Morphine Is Regulated by Spinal Glucocorticoid Receptor
J. Neurosci., November 30, 2005; 25(48): 11145 - 11154.
[Abstract] [Full Text] [PDF]
V. L. Tawfik, M. L. LaCroix-Fralish, N. Nutile-McMenemy, and J. A. DeLeo
Transcriptional and Translational Regulation of Glial Activation by Morphine in a Rodent Model of Neuropathic Pain
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1239 - 1247.
[Abstract] [Full Text] [PDF]
N. Shimoyama, M. Shimoyama, A. M. Davis, D. T. Monaghan, and C. E. Inturrisi
An Antisense Oligonucleotide to the N-Methyl-D-aspartate (NMDA) Subunit NMDAR1 Attenuates NMDA-Induced Nociception, Hyperalgesia, and Morphine Tolerance
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 834 - 840.
[Abstract] [Full Text] [PDF]
N. Takayama and H. Ueda
Morphine-Induced Chemotaxis and Brain-Derived Neurotrophic Factor Expression in Microglia
J. Neurosci., January 12, 2005; 25(2): 430 - 435.
[Abstract] [Full Text] [PDF]
S. Wang, G. Lim, Q. Zeng, B. Sung, L. Yang, and J. Mao
Central Glucocorticoid Receptors Modulate the Expression and Function of Spinal NMDA Receptors after Peripheral Nerve Injury
J. Neurosci., January 12, 2005; 25(2): 488 - 495.
[Abstract] [Full Text] [PDF]
S. Wang, G. Lim, Q. Zeng, B. Sung, Y. Ai, G. Guo, L. Yang, and J. Mao
Expression of Central Glucocorticoid Receptors after Peripheral Nerve Injury Contributes to Neuropathic Pain Behaviors in Rats
J. Neurosci., September 29, 2004; 24(39): 8595 - 8605.
[Abstract] [Full Text] [PDF]
I. N. Johnston, E. D. Milligan, J. Wieseler-Frank, M. G. Frank, V. Zapata, J. Campisi, S. Langer, D. Martin, P. Green, M. Fleshner, et al.
A Role for Proinflammatory Cytokines and Fractalkine in Analgesia, Tolerance, and Subsequent Pain Facilitation Induced by Chronic Intrathecal Morphine
J. Neurosci., August 18, 2004; 24(33): 7353 - 7365.
[Abstract] [Full Text] [PDF]
J. A. Deleo, F. Y. Tanga, and V. L. Tawfik
Neuroimmune Activation and Neuroinflammation in Chronic Pain and Opioid Tolerance/Hyperalgesia
Neuroscientist, February 1, 2004; 10(1): 40 - 52.
[Abstract] [PDF]
J. C. Ballantyne
Chronic Pain Following Treatment for Cancer: The Role of Opioids
Oncologist, December 1, 2003; 8(6): 567 - 575.
[Abstract] [Full Text] [PDF]
J. C. Ballantyne and J. Mao
Opioid Therapy for Chronic Pain
N. Engl. J. Med., November 13, 2003; 349(20): 1943 - 1953.
[Full Text] [PDF]
N.-J. Xu, L. Bao, H.-P. Fan, G.-B. Bao, L. Pu, Y.-J. Lu, C.-F. Wu, X. Zhang, and G. Pei
Morphine Withdrawal Increases Glutamate Uptake and Surface Expression of Glutamate Transporter GLT1 at Hippocampal Synapses
J. Neurosci., June 1, 2003; 23(11): 4775 - 4784.
[Abstract] [Full Text] [PDF]
B. Knight
Management of the chronic-pain patient in an acute-pain service
Can J Anesth, June 1, 2003; 50(90001): R11 - 11.
[Full Text]
B. Sung, G. Lim, and J. Mao
Altered Expression and Uptake Activity of Spinal Glutamate Transporters after Nerve Injury Contribute to the Pathogenesis of Neuropathic Pain in Rats
J. Neurosci., April 1, 2003; 23(7): 2899 - 2910.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|